ReportsnReports.com adds report Complete 2013-14 Induced Pluripotent Stem Cell Industry Report to its store. Stem cell research and experimentation has been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have caused great commercial interest, with potential applications ranging from the use of stem cells in reversal or treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Diseases such as Huntington’s Chorea, Parkinson’s Disease, and spinal cord injuries are examples of clinical applications in which stem cells could offer benefits in halting or even reversing damage.

Traditionally, scientists have worked with both embryonic and adult stem cells as research tools. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding their use for research purposes. Although some adult stem cells do have differentiation capacity, it is often limited in nature, which creates narrow options for use. Thus, induced pluripotent stem cells (iPSC cells) represent a promising combination of adult and embryonic stem cell characteristics.

Induced Pluripotent Stem Cells Discovery: Groundbreaking experimentation in 2006 led to the introduction of induced pluripotent stem cells (iPSC cells). These are adult cells which are isolated and then transformed into embryonic-like stem cells through the manipulation of gene expression, as well as other methods. Research and experimentation using mouse cells at Kyoto University in Japan was the first instance in which there was successful generation of the iPSC. In 2007, a series of follow-up experiments were done at Kyoto University in which human adult cells were transformed into iPSC cells.

While there has been continued excitement at the prospect of what such artificially re-manufactured cells could contribute to medical advances, there have also been issues along the way. By 2010, there were a number of private companies that were ready to capitalize on the breakthrough technology that iPSC represent. One such company, Advanced Cell Technology in Worcester, Massachusetts, discovered several problematic issues while conducting experiments for the purpose of applying for U.S. Food and Drug Administration approval to use Induced Pluripotent Stem Cells in therapeutic applications. Concerns such as premature cell death, mutation into cancer cells, and low proliferation rates were some of the problems that surfaced.

Research Advances: Continued research and experimentation has resulted in numerous advances over the last few years. In one example, the University of Michigan announced in “Circulation Research” (2012) that they had developed innovative methods for use of induced pluripotent stem cells derived from skin biopsies to create cardiac muscle cells. This accomplishment quickly fueled other research into the use of iPSC cells for the reversal and repair of diseased heart tissue.

Similar advances will continue to be perfected for use of reprogrammed adult cells in the treatment of other diseases and disorders. Original techniques for iPSC cells production, such as viral induced transcription processes, are being replaced with newer technologies as private industries join with the scientific community to develop safe and efficient methods of Induced Pluripotent Stem Cells production. With sustained research and experimentation, established guidelines for effective production of iPSC cells will be commonplace.

In summary, induced pluripotent stem cells represent a promising tool for use in the reversal and repair of many previously incurable diseases.

Market Metrics – iPSC cells Research Products: For this reason a large and thriving research products market has grown into existence for the cell type. The number of iPSC cells research products sold worldwide has been growing at an annual rate of 14.7% for the past five years. In addition, 22% of all stem cell researchers now self-report as having used induced pluripotent stem cells within a research project. It is clear that iPSCs are a vital research trend within the scientific community.

A distinctive feature of this “Induced Pluripotent Stem Cells Market (iPSC cells)” report is an end-user survey of 274 researchers (131 U.S. / 143 International) that identify as having induced pluripotent stem cells as their core research focus. These survey findings reveal iPSC cells researcher needs, technical preferences, key factors influencing buying decisions, and more. They can be used to make effective product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.

Remember, to benefit from this lucrative product market, you need to anticipate and serve the needs of your clients, or your competitors will.

In summary, this is a must-read industry report for research supply companies to optimally position themselves to sell iPSC cells products. To profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the marketplace, and take advantage of crucial iPSC cells market trends. Claim this report Induced Pluripotent Stem Cells market now to profit from this expanding market - or your competition will.

About Us: ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need. Not limited to the Stem Cell (http://www.reportsnreports.com/tags/stem-cell-market-research.html) ReportsnReports.com offers research studies on agriculture, energy and power, automotive, consumer goods, environment, public sector, pharmaceuticals, medical devices, IT & Telecommunication, healthcare,semiconductor and electronics, manufacturing & construction, energy and power, food and beverages, retail, water, advanced materials and much more.

Related articles

Reliability testing is a very important component of new engine development. Engineers need to fully understand and chart the engine lifetime performance under a variety of conditions before mass production may be considered. Many important performance data parameters are collected in real time through the many different types of sensors that are connected to the engine in the test cell and oil analysis is an integral part of the research process.Comprehensive real time oil analysis can provide critical information...

Overview
A Mid-western outboard engine manufacturer bought a three year-old plant for the production of its marine engines. When finished, the engines are removed from the assembly line and run for quality control. The 25,000 SCFM of exhaust from testing contains volatile organic compounds (VOCs) that require regulatory compliance. Also within this exhaust is a great deal of water vapor and carbon monoxide (CO).
Anguil Environmental had already planned to equip this plant with pollution control equipment for...

This study focuses on two main aspects: developing a novel cost-effective electrode material and power production from domestic wastewater using three different mediators. Methylene blue (MB), neutral red (NR) and 2-hydroxy-1,4-naphthoquinone (HNQ) were selected as electrode mediators with different concentrations. A tin-coated copper mesh electrode was tested as anode electrode. Maximum power density of the microbial fuel cell (MFC) with 300 μM MB was 636 mW/m2. Optimal mediator concentrations with...

This autumn sees the launch of the second edition of the EI’s handbook, 1550; a title which has become a key industry reference for everyone involved in handling aviation fuel since the first edition was issued in 2007. Martin Hunnybun, EI Technical Team Manager – Fuels & Fuel Handling, describes the new content.With over 20 specified performance parameters, jet fuel is one of the most highly specified fuels. All but one of these parameters have quantifiable limits that are measured by a range of...

Customer comments

No comments were found for 2014 - 2018 Induced Pluripotent Stem Cell Market Projections New Research Report. Be the first to comment!

Add your comment

Great! comment successfully added!

Contact

Your message:

Your email

Your first name

Your last name

I would like to receive periodic email updates and special offers from select suppliers.